Tiffany Woynaroski is assistant professor of hearing and speech sciences at Vanderbilt University Medical Center, Vanderbilt Kennedy Center, Vanderbilt Brain Institute, and Frist Center for Autism and Innovation in Nashville, Tennessee.
Tiffany Woynaroski
Assistant professor
Vanderbilt University
From this contributor
Common sensory response scores may miss important variations
A person’s “overall” score on sensory-seeking, hyperreactive or hyporeactive tendencies may obscure nuances in their individual sensory experience.
Common sensory response scores may miss important variations
Errors of omission: Why we are deeply concerned about research on autism therapies
Studies of autism treatments rarely report adverse events, and the scientists involved often fail to disclose their conflicts of interest.
Errors of omission: Why we are deeply concerned about research on autism therapies
Explore more from The Transmitter
Prevalence of profound autism declines with new definition
The updated, more precise definition used in a CDC study includes adaptive scores.
Prevalence of profound autism declines with new definition
The updated, more precise definition used in a CDC study includes adaptive scores.
Is it time for neuroscience to shift its focus from a computational mind to a navigating mind?
Andrea Hiott explains her navigational approach to the mind, and why now is the time to embrace seemingly paradoxical findings in neuroscience.
Is it time for neuroscience to shift its focus from a computational mind to a navigating mind?
Andrea Hiott explains her navigational approach to the mind, and why now is the time to embrace seemingly paradoxical findings in neuroscience.
Human brain organoids come of age—but still have room to grow
The U.S. government has touted organoids as an alternative to animals for studying the brain. The model has improved since its debut in 2013, but scientists are still working to overcome key limitations: immaturity, consistency and the lack of vascularization.
Human brain organoids come of age—but still have room to grow
The U.S. government has touted organoids as an alternative to animals for studying the brain. The model has improved since its debut in 2013, but scientists are still working to overcome key limitations: immaturity, consistency and the lack of vascularization.